Saturday 20 Apr 2024
By
main news image

This article first appeared in The Edge Financial Daily on October 1, 2019

Malaysian Genomics Resource Centre Bhd (-ve)

TRADING of shares in Malaysian Genomics Resource Centre Bhd (fundamental: 0.35/3, valuation: 0.3/3) triggered our momentum algorithm yesterday for the second time this year.

The counter closed one sen or 3.45% lower at 28 sen, after some 50,100 were traded, about seven times more than its 200-day average trading volume of 7,315 shares.

The company’s principal activities include enabling personalised and precision medicine by combining genetics and genomics testing with clinical pathology laboratory services, genome sequencing and bioinformatics services as well as investment holding.

For the financial year ended June 30, 2019, the group’s net loss narrowed to RM3.84 million from RM4.53 million a year ago, as it registered a 5.99% rise in revenue to RM27.73 million from RM26.16 million.

The lower loss recorded “was mainly due to higher pathology revenue”, the group said when the results were released.

      Print
      Text Size
      Share